Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing

This document is a Response to Comments regarding MolDX Local Coverage Determination L37750 for Melanoma Risk Stratification Molecular Testing and does not itself provide specific coverage, indication, limitation, or documentation criteria. The LCD L37750 notice period began 2022-06-23 and the LCD becomes effective 2022-08-08; the comment period was 2021-05-20 to 2021-07-03. Review the full LCD L37750 for detailed coverage criteria and requirements.

"This document is a Response to Comments for MolDX: Melanoma Risk Stratification Molecular Testing Local Coverage Determination L37750; it summarizes stakeholder comments and administrative timeline..."

Sign up to see full coverage criteria, indications, and limitations.